Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) EBT: 2024-2025

Historic EBT for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to -$74.1 million.

  • Kura Oncology's EBT fell 36.23% to -$74.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$214.6 million, marking a year-over-year change of. This contributed to the annual value of -$172.0 million for FY2024, which is 12.67% down from last year.
  • Kura Oncology's EBT amounted to -$74.1 million in Q3 2025, which was down 12.09% from -$66.1 million recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's EBT peaked at -$17.2 million during Q4 2024, and registered a low of -$74.1 million during Q3 2025.
  • For the 2-year period, Kura Oncology's EBT averaged around -$52.8 million, with its median value being -$54.4 million (2024).
  • Data for Kura Oncology's EBT shows a maximum YoY slumped of 36.23% (in 2025) over the last 5 years.
  • Over the past 2 years, Kura Oncology's EBT (Quarterly) stood at -$17.2 million in 2024, then crashed by 36.23% to -$74.1 million in 2025.
  • Its last three reported values are -$74.1 million in Q3 2025, -$66.1 million for Q2 2025, and -$57.2 million during Q1 2025.